Uracil DNA Glycosylase Counteracts APOBEC3G-Induced Hypermutation of Hepatitis B Viral Genomes: Excision Repair of Covalently Closed Circular DNA by Kitamura Kouichi et al.
Uracil DNA Glycosylase Counteracts
APOBEC3G-Induced Hypermutation of Hepatitis B
Viral Genomes: Excision Repair of Covalently
Closed Circular DNA
著者 Kitamura Kouichi, Wang Zhe, Chowdhury Sajeda,










Uracil DNA Glycosylase Counteracts APOBEC3G-Induced
Hypermutation of Hepatitis B Viral Genomes: Excision
Repair of Covalently Closed Circular DNA
Kouichi Kitamura, Zhe Wang, Sajeda Chowdhury, Miyuki Simadu, Miki Koura, Masamichi Muramatsu*
Department of Molecular Genetics, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
Abstract
The covalently closed circular DNA (cccDNA) of the hepatitis B virus (HBV) plays an essential role in chronic hepatitis. The
cellular repair system is proposed to convert cytoplasmic nucleocapsid (NC) DNA (partially double-stranded DNA) into
cccDNA in the nucleus. Recently, antiviral cytidine deaminases, AID/APOBEC proteins, were shown to generate uracil
residues in the NC-DNA through deamination, resulting in cytidine-to-uracil (C-to-U) hypermutation of the viral genome. We
investigated whether uracil residues in hepadnavirus DNA were excised by uracil-DNA glycosylase (UNG), a host factor for
base excision repair (BER). When UNG activity was inhibited by the expression of the UNG inhibitory protein (UGI),
hypermutation of NC-DNA induced by either APOBEC3G or interferon treatment was enhanced in a human hepatocyte cell
line. To assess the effect of UNG on the cccDNA viral intermediate, we used the duck HBV (DHBV) replication model.
Sequence analyses of DHBV DNAs showed that cccDNA accumulated G-to-A or C-to-T mutations in APOBEC3G-expressing
cells, and this was extensively enhanced by UNG inhibition. The cccDNA hypermutation generated many premature stop
codons in the P gene. UNG inhibition also enhanced the APOBEC3G-mediated suppression of viral replication, including
reduction of NC-DNA, pre-C mRNA, and secreted viral particle-associated DNA in prolonged culture. Enhancement of
APOBEC3G-mediated suppression by UNG inhibition was not observed when the catalytic site of APOBEC3G was mutated.
Transfection experiments of recloned cccDNAs revealed that the combination of UNG inhibition and APOBEC3G expression
reduced the replication ability of cccDNA. Taken together, these data indicate that UNG excises uracil residues from the viral
genome during or after cccDNA formation in the nucleus and imply that BER pathway activities decrease the antiviral effect
of APOBEC3-mediated hypermutation.
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Introduction
The hepatitis B virus (HBV) is one of the major causative factors
of liver cirrhosis and hepatocellular carcinoma. Chronic inflam-
mation due to persistent HBV infection plays a major causative
role in these severe liver diseases. However, it is still unknown how
HBV establishes persistent infection and how this infection results
in these diseases [1,2]. The HBV genome in virions forms a
relaxed circular DNA (rcDNA) that is converted into covalently
closed circular DNA (cccDNA) in the nuclei of infected
hepatocytes. The cccDNA transcribes all viral RNAs including
pregenomic (pg) RNA as a replicative RNA intermediate. In the
cytoplasm, pgRNA, viral core, and polymerase proteins are
assembled into the nucleocapsid (NC), after which the pgRNA is
converted into an rcDNA by viral polymerase activity. The mature
NCs are transferred to either the endoplasmic reticulum to be
secreted after combining with envelope proteins or the nucleus to
form cccDNA again for the next replication cycle. Although the
host repair system is thought to play a major role in conversion of
rcDNA into cccDNA, the molecules responsible for the conversion
have not been determined experimentally [3,4,5].
cccDNA plays a key role in the persistence of viral infection
because it is maintained as a stable episome in the nucleus.
Moreover, cccDNA is not targeted by anti-HBV drugs and thus
enables the re-establishment of viral replication after cessation
of antiviral therapy [4,6,7]. Despite the importance of cccDNA
in HBV chronic infection, host factors that control cccDNA are
poorly understood in the absence of an efficient experimental
system that can produce HBV cccDNA at a level sufficient for
analysis. In view of the limitation of HBV in vitro systems, the
duck HBV (DHBV) model has been commonly used to study
HBV infection [8]. DHBV is an avian counterpart of HBV,
sharing fundamental features including genomic organization,
replication processes, and biological characteristics [9]. Impor-
tantly, DHBV produces cccDNA more efficiently than HBV
[10].
Previously, we isolated a B-cell-specific gene, activation-
induced cytidine deaminase (AID), which is essential for class-
switch recombination and somatic hypermutation of immuno-
globulin genes [11,12]. AID belongs to the APOBEC (apolipo-
protein B mRNA editing catalytic polypeptide) family of proteins.
In humans, this family comprises at least 11 members, including
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AID and APOBECs 1, 2, 3A, 3B, 3C, 3DE, 3F, 3G, 3H, and 4.
These AID/APOBEC proteins have enzyme activity that can
deaminate a cytidine base in DNA and/or RNA and thereby
generate a uridine base. APOBEC3G (A3G) restricts replication
of retroviruses, including human immunodeficiency virus type 1
(HIV-1), and retrotransposable elements [13,14,15]. A3G has
been shown to also restrict other viruses such as HBV
[16,17,18,19,20,21,22,23,24], but the exact mechanism of
restriction of HBV replication remains unresolved. Earlier studies
suggested that accumulation of extensive G-to-A (in an opposite
strand of C-to-U) hypermutation in retroviral DNA might initiate
the deamination-mediated restriction pathway of A3G [25,26].
However, such hypermutation may not account for rapid
reduction of HBV NC-DNA by A3G overexpression because
only a limited fraction of NC-DNA accumulates these extensive
mutations [16,19,27,28]. Another proposed mechanism is that
A3G is encapsidated within NC with pgRNA and interferes in the
process of minus-stranded DNA synthesis, such that a catalyti-
cally inactive mutant of A3G has been shown to still inhibit viral
replication [19,21]. Deaminase-independent restriction by A3G
has also been demonstrated for HIV-1 [14,15].
Human uracil DNA glycosylase (UNG) is a base excision repair
(BER) enzyme that removes uracil residues from DNA following
dUTP misincorporations or cytosine deaminations [29]. UNG is
also essential for class-switch recombination and somatic
hypermutation. In UNG deficiency (human and mouse), class-
switch recombination is markedly reduced because uracil bases
generated by AID do not produce DNA strand breaks in the
absence of UNG. However, UNG-deficient mice and patients
accumulate more frequent C-to-T and G-to-A somatic hypermu-
tations because uracil bases generated by AID remain as thymine
residues in UNG-deficient condition [29,30]. The UNG gene
encodes 2 alternative splicing isoforms with unique N-terminal
amino acid sequences, mitochondrial type UNG1 and nuclear
type UNG2. Early HIV-1 studies showed that UNG2 is
encapsidated into the virion through physical association with
the Vpr protein and reduces the mutation rate of viral DNA
[31,32]. However, the contribution of UNG activity to APO-
BEC3 (A3)-mediated HIV-1 restriction is controversial. Yang et
al. proposed that uracil residues generated by A3G might be
eliminated by UNG associated with Vpr and that subsequent
DNA cleavage of abasic sites by apurinic/apyrimidinic endonu-
clease-1 (APE-1) might occur [33]. Meanwhile, other groups
reported that A3G-mediated HIV-1 restriction occurs even in the
absence of UNG [34,35,36]. Importantly, HBV does not harbor
the Vpr counterpart, and UNG encapsidation in HBV particles
has not been reported. Unlike HIV-1, HBV forms episomal
cccDNA, which is a potential target for nuclear UNG activity;
however, whether APOBECs can hypermutate the cccDNA and
whether UNG has any role in cccDNA maintenance has not been
investigated.
In the present study, we investigated the possible role of UNG in
A3G-mediated antiviral activities on HBV and DHBV. When
UNG activity was inhibited by expression of the UNG inhibitory
protein (UGI), hypermutation of HBV and DHBV NC-DNA was
enhanced in A3G-expressing hepatocytes. We found that more
than half of DHBV cccDNA clones accumulated extensive
hypermutation by A3G overexpression and UNG inhibition.
Moreover, we demonstrated that the cccDNA isolated from cells
expressing both A3G and UGI showed decrease in replication
activity. These experimental observations indicate that UNG
efficiently repairs dysfunctional C-to-U mutations induced by A3G
in cccDNA.
Results
UNG inhibition enhanced A3G-induced hypermutation of
HBV NC-associated DNA
To investigate the potential role of UNG in HBV hypermuta-
tion, the UNG activity of the human hepatocyte cell line HepG2
was suppressed with UGI, which is an irreversible inhibitor that
forms an exceptionally stable complex with the UNG protein
[37]. We generated the HepG2 cell line that stably expressed
the UGI–estrogen receptor (ER) protein by retrovirus-mediated
gene transduction following drug selection. We had previously
demonstrated that the addition of an ER ligand, 4-hydro-
xytamoxifen (OHT), to the culture medium activated the
enzymatic activity of the fusion partner [38,39]. Accordingly,
we reasoned that expression of the UGI–ER fusion protein
could be applied to control UNG activity in HBV-replicating
cells. The UNG assay revealed that OHT stimulation of the
UGI–ER protein resulted in very limited UNG activity,
amounting to 7% of the activity in the parental HepG2 cells,
whereas 97% of activity remained in unstimulated (EtOH) cells
(Figure 1A). Using this cell line, we estimated the effects of UNG
inhibition on A3G-induced hypermutation of HBV NC-DNA.
An HBV replicon plasmid, pHBV1.5 [40,41], was cotransfected
with the FLAG-tagged A3G expression plasmid [or green
fluorescent protein (GFP) as a negative control] into the UGI–
ER HepG2 cells. Three days after transfection, the cells were
harvested and cytoplasmic NCs were purified. The NC-DNA
was analyzed by differential DNA denaturation polymerase
chain reaction (3D-PCR) on a region of the X gene [28]. The
3D-PCR technique is a highly sensitive assay for detecting AT-
rich DNA. It was applied to reveal the presence of hypermuta-
tion in NC-DNA. Consistent with reports from other groups
[18,19,23,24,28,42,43], A3G expression induced HBV hyper-
mutation, represented as a lower denaturation temperature
band (83.9uC) than negative controls in 3D-PCR (Figure 1B).
OHT addition enhanced the hypermutation in the A3G-
expressing cells because the band was detected at the lowest
Author Summary
Human cytidine deaminases, AID/APOBECs, are restriction
factors against various types of viruses. These proteins
have the ability to introduce a cytidine-to-uridine (C-to-U)
hypermutation in the viral DNAs of the hepadnaviruses
hepatitis B virus (HBV) and duck HBV (DHBV) models. It is
well known that uracil residues in human genomic DNA
are removed by uracil-DNA glycosylase (UNG), resulting in
the creation of abasic sites that are repaired by down-
stream repair factors. However, the consequence of uracil
removal from the viral genomic DNA remains controver-
sial, given that it may be possible for abasic sites to trigger
DNA degradation with strand breakage. We investigated
the role of UNG in viral hypermutation and hepadnaviruses
replication using in vitro cell culture systems. We found
that UNG inhibition enhanced APOBEC3G-induced hyper-
mutation of hepadnaviral DNAs, especially DHBV cccDNA,
a template used for viral replication in the nucleus. We
measured the replication ability of purified cccDNA and
found that recloned cccDNA from cells expressed by both
APOBEC3G and UNG inhibitor protein replicated less
efficiently due to higher hypermutation rates. These results
suggest that hepadnaviruses usurp the repair system of
host cells to compete with AID/APOBEC mutators.
UNG Counteracts Extensive Hypermutation of cccDNA
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melting temperature (83.0uC). OHT addition did not influence
A3G transgene expression in these cells (Figure 1C). The 83.9uC
PCR products shown in Figure 1B were cloned and sequenced.
As predicted by the 3D-PCR assay, the cloned PCR fragments
accumulated extensive G-to-A mutations (Figure 1D).
We also suppressed UNG activity using a short-interfering RNA
(siRNA) approach to avoid any artifacts due to the UGI–ER
inducible activation system. We used 293T cells for the siRNA
experiment because of better transfection efficiency of the siRNA
than that afforded by HepG2 cells. For viral replication in human
embryonic kidney 293T cells, another replicon plasmid pPB that
expresses HBV pgRNA by the CMV promoter was used [44,45].
The UNG assay revealed that both UNG-specific siRNAs reduced
UNG activity in 293T cells, although at low suppression efficiency
(a maximum of 47% of the control; Figure S1A). Nonetheless, 3D-
PCR showed amplification at a slightly lower denaturation
temperature, indicating the presence of hypermutated HBV
DNA from the UNG-specific siRNA-treated cells (Figure S1B).
These data indicate that inhibition of UNG activity increases
A3G-induced hypermutation of HBV NC-DNA.
UNG inhibition enhanced endogenous deaminase-
induced hypermutation of HBV NC-associated DNA
Next, we investigated whether the enhancement of hypermuta-
tion by UNG inhibition was reproduced by endogenous AID/
APOBEC3 proteins. We generated a stable HepG2 cell line that
constitutively supports both HBV replication and UGI–ER
expression in order to establish a transfection-free system (see
Materials & Methods for details). Inhibition of UNG activity by
OHT addition in this cell line was confirmed by the UNG assay
(Figure 2A). IFNc was used to stimulate the cells to induce
endogenous APOBEC deaminases, and changes in deaminase
gene expression levels were measured by quantitative reverse
transcription-PCR (qRT-PCR). Consistent with that in previous
studies [20,46,47], A3G was the major responder to IFNc
stimulation among AID/APOBEC3s (A3s) in this cell line
(Figure 2B). The hypermutation load on NC-DNA in IFNc-
stimulated UGI–ER HepG2 was analyzed by 3D-PCR. Our
analyses revealed that UNG inhibition enhanced IFNc-induced
NC-DNA hypermutation (Figure 2C). To evaluate the contribu-
tions of endogenous APOBEC3G, we used A3G-specific siRNAs.
Figure 1. UNG inhibition enhances A3G-induced hypermutation of HBV NC-associated DNA. (A) Uracil excision activity was measured
using an UNG assay with a synthetic single-stranded DNA containing a dU. UGI–ER-expressing HepG2 and parental cells were treated with either
1 mM OHT or the same amount of solvent (ethanol, EtOH) for 48 h, and UNG activity was measured. Asterisk (*), abasic site. The percent density of
signals for the 15-mer is indicated. Signal density of the OHT-treated HepG2 cells was defined as 100%. (B) The HBV replicon plasmid (pHBV1.5) and
FLAG-A3G or FLAG-GFP expression vectors were used to transfect the UGI–ER HepG2 cells. Twenty-four hours after transfection, 1 mM OHT (or EtOH)
was added to activate the UGI–ER protein. After further 48-h incubation, the cells were harvested and the HBV NC-DNA was purified. HBV DNAs from
each transfectant were amplified by 3D-PCR with denaturation temperature gradient of 94–83uC. (C) Expression of exogenous A3G and GFP proteins
in the conditions of (B) was determined by Western blotting with anti-FLAG antibody. Expression of GAPDH is also shown to demonstrate equivalent
protein loading. (D) Alignment of hypermutated HBV sequences. PCR fragments from the 83.9uC denaturation temperature reaction in (B) were
excised from agarose gel and cloned into T vectors, and then 4 randomly selected clones from each sample were sequenced. The sequence (GenBank
accession number: X02763) from the pHBV1.5 is shown on the top as a reference. Dots in the alignment represent identity to the reference sequence.
doi:10.1371/journal.ppat.1003361.g001
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The efficiency of siRNA knockdown was determined by qRT-
PCR (Figure S1C). As shown in Figure 2D, the knockdown of
A3G expression counteracted the induction of hypermutation by
IFNc, suggesting that A3G is responsible for HBV hypermutation
induced by IFNc stimulation. The 87.2uC PCR products shown in
Figure 1D were cloned and sequenced, and confirmed the
hypermutation (Figure S1D). These data suggest that UNG
counteracts the deamination of HBV NC-DNA triggered by
endogenous A3s.
Most HBV NC-associated DNAs were not affected by UNG
inhibition
To determine the overall hypermutation frequency of HBV
DNA, we sequenced the NC-DNA from the A3G-transfected
UGI–ER HepG2. PCR fragments of the X gene partial sequence
(94uC for denaturation) of NC-DNA were cloned in a T vector.
Fifty clones of each sample were randomly selected for DNA
sequencing. Figure 3A shows the mutations found in the
sequenced clones. Consistent with 3D-PCR results, the total G-
to-A mutation frequency was enhanced by UNG inhibition in
A3G transfectants (indicated as ‘‘A3G, OHT’’ in Figure 3).
However, 39 of the 50 sequenced clones were free from
hypermutation in both UNG-inhibited and uninhibited cells
(Figure 3B). Previous studies [16,19,27,28] also reported few
clones harboring A3G-induced mutations in NC-DNA.
Since UNG inhibition enhanced hypermutation, we next
investigated whether UNG inhibition affects another antiviral
activity of A3G, the suppression of NC-DNA production.
Cytoplasmic HBV NC-DNA was quantified by native agarose
gel electrophoresis (NAGE) followed by Southern blotting. NAGE
specifically separates intact NC particles, and after the NC
particles are transferred to a nylon filter, the DNA content in the
NC fraction is measured by hybridization analysis with the HBV
DNA probe [21,22,48]. As shown in Figure 4A, Southern blotting
after NAGE revealed that A3G reduced the NC-DNA content, a
result consistent with previous reports [16,17,18,19,20,21,
22,23,24]. We found that the signal intensity of NC-DNA band
from A3G-UGI cotransfectants were slightly higher than that from
A3G transfectants in HepG2 cells. However, A3G-mediated
reduction was not disturbed by UNG inhibition in Huh7 cells.
Quantitative PCR (qPCR) analyses of the NC-DNA revealed no
appreciable difference between the presence and absence of UGI
in HepG2 cells (Figure 4B). We concluded that UNG did not affect
A3G-mediated reduction of NC-DNA, although enhanced
hypermutation was observed in the same experimental culture
conditions for 3 days.
Figure 2. UNG inhibition enhances the endogenous deaminase-induced hypermutation of HBV NC-associated DNA. (A) Uracil excision
activity in a HepG2 double-stable transfectant of UGI–ER (or Mock–ER) and HBV was assessed as in Figure 1A (left panel). Expression of UGI–ER and
mock–ER proteins was confirmed by Western blotting with anti-ER antibody (right panel, indicated by arrowheads). (B) Quantification of the
expression of AID/APOBECs on interferon stimulation. HepG2 cells were stimulated with 1000 U/mL IFNc for 24 or 48 h. qRT-PCR was performed to
determine the expression level for each deaminase. Under these conditions, AID (AICDA) and A3A expression were not detected (n.d.). Expression at
0 h was defined as a 1-fold change. (C) 3D-PCR analysis of the stable double transfectants of UGI–ER and HBV used in (A). The cells were treated with
1000 U/mL IFNc and 1 mM OHT as indicated. After the 48-h incubation, the cells were harvested and the HBV NC-DNA was analyzed. (D) 3D-PCR
analysis of the IFNc-stimulated and A3G knockdown cells. The A3G-specific (or control) siRNAs and pPB were used to transfect HepG2 cells, and at
16 h after transfection, the cells were treated with 1000 U/mL IFNc. After further 48-h incubation, the HBV NC-DNA was purified and analyzed. PCR
fragments (87.2uC) indicated by an arrow were sequenced and the results were shown in Figure S1D.
doi:10.1371/journal.ppat.1003361.g002
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To observe possible encapsidation of the UNG protein in the
HBV NCs, we evaluated the physical association between NC and
UNG by immunoprecipitation (IP). Nuclear type of UNG (UNG2)
was overexpressed together with the HBV plasmid pPB and
FLAG-A3G expression vector in 293T cells. The cytoplasmic
fraction containing NCs was used for IP with anti-core (HBc)
antibody and Western blotting. As shown in Figure S2A,
endogenous mitochondrial UNG (UNG1) was clearly detected in
input from the cytoplasmic fractions. Leaked UNG2 from the
nucleus was also detected in the input. As reported previously [18],
the A3G protein was immunoprecipitated with anti-HBc antibody.
However, the signals for UNG2 and GFP disappeared after IP,
suggesting that the A3G protein but not the UNG protein is
encapsidated into NC. Faint signals for UNG1 were still observed
in all lanes of the IP samples at equal signal strength, suggesting
nonspecific capture of the UNG1 protein on the protein G
sepharose beads. We also investigated the subcellular localization
of the UNG2 protein in human hepatocytes. GFP-fused UNG2
localized in the nucleus even in HBV-replicating HepG2 cells
(Figure S2B). Taken together, these findings did not reveal
evidence for the NC-associated UNG protein, although the NC
UNG protein level below detection sensitivity may be sufficient to
change the NC-DNA hypermutation frequency.
DHBV cccDNA was extensively hypermutated by A3G
and repaired via the UNG-mediated BER pathway
We next investigated whether the nuclear viral intermediate,
cccDNA, is a target of UNG activity. Since analysis of cccDNA
has been difficult using our HBV in vitro model because of the low
abundance of cccDNA (data not shown), we exploited the DHBV
replication system, which efficiently produces cccDNA for analysis
[9,10]. In this study, the surface-deficient DHBV replicon plasmid
pCSD3.5DS was used to transfect a chicken hepatocyte cell line,
LMH, because deficiency of surface protein leads to accumulate
more cccDNA than wild-type DHBV [10,49]. The UNG assay
indicated that UGI transfection resulted in efficient decrease in
UNG activity even in the LMH cell (Figure 5A). Inhibition of
chicken UNG by UGI has been reported previously [50,51].
Western blotting confirmed that the expression levels of A3G and
catalytically inactive mutant (mutA3G) transgenes were not
influenced by UGI (Figure 5B). The DHBV plasmid was
cotransfected with A3G and UGI vectors into LMH cells. After
3 days, the cells were harvested and NC-DNA was analyzed by
3D-PCR [23] (primer position is indicated in Figure S3A). Data
indicate that amplification occurred at the lowest temperature
(83uC) from A3G transfectants both with and without UGI
expression (Figure 5C), indicating that the A3G protein can
hypermutate DHBV NC-DNA. NC-DNA fragments amplified by
a standard PCR (94uC) were cloned into the T vector and 10
clones were randomly selected for DNA sequencing. These
sequences are shown in Figure 5D (indicated as ‘‘NC-DNA’’)
and Figure S3B. Consistent with other HBV experiments
(Figure 3), these data demonstrate the enhanced hypermutation
of NC-DNA by UNG inhibition.
Next, cccDNA was isolated by nuclear Hirt extraction and
further treated with DpnI to digest transfected plasmids. A
cccDNA fragment (1.4 kb) was amplified by standard PCR (94uC)
using cccDNA-selective primers spanning the gap region of
rcDNA (Figure S3A) [52,53]. We tested the amplification
efficiency of DNAs from nuclear Hirt extract, secreted viral
particle, and the replicon plasmid to verify the specificity of
cccDNA-selective PCR (Figure S3C). As expected, the 1.4 kb
fragment was predominantly amplified from the nuclear Hirt
extract containing cccDNA. We also evaluated the specificity of
the cccDNA-selective PCR with a replication-defected DHBV
replicon plasmid (pCSD3.5DP). The cccDNA-selective PCR
amplified the 1.4 kb fragment from transfectants of the replica-
tion-competent plasmid but not from those of replication-defective
plasmid (pCSD3.5DP) (Figure S3D). The result clearly demon-
strates that our cccDNA-selective PCR amplifies the 1.4 kb from
nuclear viral DNA but not from replicon plasmid.
We compared the mutation frequency of cccDNA with those of
NC-DNA and pre-C mRNA. Ten randomly selected clones from
the A3G-UGI cotransfectants and A3G alone were sequenced,
Figure 3. Mutation frequency of HBV NC-associated DNA in A3G expression and UNG inhibition. DNA fragments amplified through
standard PCR (94uC in Figure 1B) were cloned into T vectors. NC-DNA sequences from randomly selected 50 clones were analyzed for each group. (A)
Mutation matrices of the HBV NC-DNA with or without A3G expression and in the presence or absence of OHT. *P,0.05. The statistical significance
for the frequency of G-to-A mutations was calculated by chi-square test. (B) Pie charts represent the proportion of clones with G-to-A and C-to-T
mutations for (A). The total number of sequenced clones is indicated in the center. The number of mutations is indicated on the periphery of the pie
segment. Thirty-nine clones were intact in both samples (white segment, 0 mutation). The satellite chart depicts the proportion of clones with more
than 2 mutations.
doi:10.1371/journal.ppat.1003361.g003
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and the mutation frequencies were compared (Figure 5D).
Surprisingly, cccDNA clones from the A3G-UGI cotransfectants
were hypermutated much more extensively than NC-DNA.
Increase in the G-to-A mutation frequency was observed not only
in the mutation load per clone but also in the number of clones
harboring hypermutation. Eight of 10 cccDNA clones from A3G-
UGI cotransfectants carried at least 1 G-to-A/C-to-T mutation,
whereas hypermutation was much less frequent on the cccDNA
derived from the A3G transfectants. Interestingly, enhanced
hypermutations by A3G-UGI were also observed in cDNA clones
derived from pre-C mRNA (Figure 5D). The pre-C mRNA is
transcribed from cccDNA but not from the replicon plasmid.
Overlapping sequences of 2 PCR-amplified regions for NC-DNA
and cccDNA (Figure 5E) showed that hypermutation was
distributed throughout the P gene and that its distribution patterns
were similar between samples. Extensive G-to-A hypermutation by
A3G and UGI in this region was confirmed. As expected,
mutations were biased toward the GpG dinucleotide, a preferen-
tial target of A3G (the underlined nucleotide represents a mutation
position) [28]. Considering the dinucleotide preference, the in-
frame TGG codon must be susceptible to nonsense mutations
(TGA, TAG, and TAA). In this sequence analysis, 6 of 10 clones
of cccDNA from A3G-UGI cotransfectants had premature stop
codons in the viral P gene open reading frame (ORF), suggesting
an effect on downregulation of viral replication. To estimate the
overall mutation frequency of the cccDNA, 2.9-kb PCR fragments
corresponding to 98% of the whole viral genome were amplified
by standard PCR (94uC) and cloned in the T vector. Seven clones
were randomly selected from each group and sequenced.
Mutation matrices of cccDNA are shown in Figure 5F. As
expected from Figure 5D, much more frequent G-to-A mutations
were detected in the cccDNA from A3G-UGI cotransfectants than
in those from other samples. We observed similar mutation
frequencies between the C and P genes (data not shown). Only a
few mutations (2 mutations in 7920 nt) in the neomycin-resistant
gene of the transfected plasmid (Figure S3E) were detected. The
results indicate that cccDNA was extensively hypermutated, while
the transfected plasmid was not, in A3G-UGI cotransfectants.
Since nuclear cccDNA was highly mutated by A3G and UGI
coexpression, we investigated the subcellular localization of A3G
in LMH cells. Microscopic observation revealed that the majority
of GFP–A3G fusion proteins were localized in the cytoplasm and
that the nuclear A3G protein was not obvious even in DHBV-
replicating LMH cells (Figure S4). The data indicate that even the
A3G protein in LMH cells localizes in the cytoplasm in a manner
similar to that in mammal cells [18,54,55,56] and that the
extensive hypermutation in cccDNA is not due to misregulation of
A3G intracellular localization.
UNG inhibition reduced DHBV replication in the presence
of A3G
To assess the role of UNG in the A3G-induced suppression of
DHBV replication, cytoplasmic and nuclear viral DNAs were
analyzed by Southern blotting at days 3 and 6 after transfection.
A3G-induced suppression was obvious in all samples of NC-DNAs
and cccDNAs from both days (Figure 6A and B). The suppression
occurred in a deaminase-dependent manner, given that the
mutant A3G did not reduce the DHBV DNA levels. Similar to
the HBV result in Figure 4, UNG inhibition by UGI did not affect
the A3G-mediated reduction of NC-DNA and cccDNA at day 3.
However, at day 6, UGI expression enhanced the NC-DNA
reduction of A3G-expressing cells, while the cccDNA level of the
same transfectants was slightly increased (Figure 6B, lanes 3 and
6). We also performed qPCR to analyze the secreted virion DNA
levels from day 2 to 6 after transfection of wild-type DHBV, A3G,
and UGI vectors (Figure 6C and D). Culture supernatant was
collected daily and viral particles were precipitated by polyethyl-
ene glycol (PEG) precipitation. Purified DNA from the precipitants
was treated with DpnI to digest any contaminating plasmids. In
comparison with A3G alone, secreted viral particle-associated
DNA levels in cells cotransfected with A3G and UGI were not
significantly different at days 2 and 3. However, consistent with the
cytoplasmic Southern blotting data, at day 5, the level of secreted
viral DNA in A3G and UGI cotransfectants was lower than that of
A3G transfectants (Figure 6C and D).
We also analyzed pre-C mRNA expression levels in day 5
samples. Since pre-C mRNA is transcribed from cccDNA but not
from the replicon plasmid, pre-C mRNA expression reflects
functional activity of the upstream viral intermediate, cccDNA. As
Figure 4. UNG does not affect HBV NC-associated DNA levels
during 3 days of culture. (A) Analyses of HBV NCs by NAGE. The
CMV-driven HBV plasmid (pPB) and indicated vectors were transfected
into human hepatocyte cell lines (Huh7 or HepG2). mutA3G is a
deaminase-inactive mutant of A3G (E67Q/E259Q). Cells were harvested
72 h after transfection. Cytoplasmic extracts were subjected to NAGE to
measure the HBV NC-DNA by Southern blotting. (B) Quantification of
cytoplasmic HBV DNA in HepG2 cells in (A) by qPCR. The level of GFP
transfectants was defined as 1-fold. Asterisks indicate statistically
significant differences, *P,0.05.
doi:10.1371/journal.ppat.1003361.g004
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Figure 5. DHBV cccDNA was extensively hypermutated by A3G and repaired via the UNG-mediated BER pathway. (A) Uracil excision
activity in the UGI-transfected LMH cells. LMH cells were transfected with different amounts of the UGI vector (1, 2, and 3 mg for 60-mm dish), and
after 48-h incubation, uracil excision activities were determined. The signal density for the 15-mer in the lane of the mock transfectant (0 mg of UGI
input) was defined as 100%. Synthetic oligonucleotides (substrate and control 15-mer) were also electrophoresed as size markers. (B) Expression
levels of exogenous A3G and mutA3G proteins with or without UGI in LMH cells were confirmed by Western blotting with anti-A3G antibody.
Expression of GAPDH was also shown to demonstrate equivalent protein loading. (C) The surface-deficient DHBV replicon plasmid (pCSD3.5DS) and
GFP, A3G, or UGI expression vectors were used to transfect LMH cells as indicated. After 72-h incubation, the cells were harvested and the NC-DNA
was purified and amplified by 3D-PCR, using a denaturation temperature gradient of 94–83uC. (D) Frequency of G-to-A and C-to-T mutations in DHBV
NC-DNA, cccDNA, and pre-C mRNA. LMH cells were transfected with pCSD3.5DS and A3G with or without UGI-expressing vectors. After 6 days of
incubation, the cells were harvested. After standard (94uC denaturation) PCR and sequencing, frequencies of G-to-A and C-to-T mutations in NC-DNA
(nt 371–2419, the numbering of the nucleotide of the 3021-bp-length DHBV genome starts at the unique EcoRI site), cccDNA (nt 2476–3021/1–860),
and cDNA of pre-C mRNA (the same region as cccDNA) were determined and compared. Physical maps are presented in Figure S3A. Each plot
represents an independent clone (10 clones for each sample). The average mutation load per clone was indicated by horizontal lines. Asterisks
indicate statistically significant differences, *P,0.05. (E) Distribution of G-to-A hypermutation. The boxes in illustration represent 96 G bases within
the overlapping sequenced region (490 nt) between NC-DNA and cccDNA. All NC-DNA and cccDNA clones in (D) containing at least 1 G-to-A
mutation in the overlapping region are plotted. Black, G-to-A mutation; white, intact G; gray, 59-GpG-39 dinucleotide (the underline represents
possible mutation target). Position of the TGG codon of the P gene is indicated by double asterisks. The TGG codon can be converted to a premature
stop codon when G-to-A conversion occurs. (F) Mutation matrices of the cccDNA. The longer cccDNA fragments (2960 bp; nt 2624–3021/1–2562)
were amplified with standard PCR using the same cell source as in (D) and sequenced. DNA sequences that cover almost the complete DHBV genome
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(3021 bp, full-length) from 7 clones were analyzed for each sample. ****P,0.001. The statistical significance for the frequency of G-to-A mutations
was calculated by chi-square test.
doi:10.1371/journal.ppat.1003361.g005
Figure 6. UNG inhibition affects DHBV replication during 6 days of culture. (A and B) Southern blotting for cytoplasmic and nuclear DHBV
DNAs at day 3 (A) or day 6 (B) after transfection, with the same conditions as in Figure 5. NC-DNA (rcDNA and double-strand linear [dl]DNA) from the
cytoplasmic fraction and Hirt-extracted DNA from the nuclear fraction were purified from the indicated transfectants and subjected to Southern
blotting with a DHBV probe. (C) The wild-type DHBV replicon plasmid (pCSD3.5) and A3G vectors were cotransfected with or without the UGI vector.
At days 2–6 after transfection, DHBV DNA from secreted viral particles was purified and measured by qPCR assay. Graph shows the relative DHBV DNA
level from the A3G-UGI transfectants in the time course. The DNA level from the A3G transfectants was set as 1. **P,0.01. (D) Relative DNA levels of
the secreted DHBV. LMH cells were transfected with indicated vectors. DHBV DNAs from secreted viral particles at days 3 and 5 after transfection were
purified and measured by qPCR assay. Vertical axis shows the relative DHBV DNA level from the indicated transfectants. The DNA level from the GFP
transfectants of each time point was set as 1. **P,0.01. (E) qRT-PCR to determine the expression levels of pre-C mRNA at day 5 in indicated LMH
transfectants. The pre-C cDNA level from the GFP transfectants was set as 1. **P,0.01.
doi:10.1371/journal.ppat.1003361.g006
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shown in Figure 6E, qRT-PCR showed a consistent reduction
with result of Figure 6D.
To evaluate the outcome of cccDNA hypermutation by A3G
expression and UNG inhibition, we used rolling circle amplifi-
cation (RCA), a method widely used to prove the presence of
covalently closed circular DNA, including cccDNA of HBV and
episomes of human papillomavirus [57,58] (Figure 7A and S5).
cccDNAs were purified from cells 7 days after transfection and
then treated with DpnI. The cccDNA was amplified by RCA and
digested with EcoRI to cleave the concatemer into individual full-
length viral genomes (3.0 kb, Figure 7A). The samples containing
cccDNA show 3.0-kb bands (Figure 7A, lanes 1–4), whereas a
control RCA reaction of the DHBV plasmid (lane 5) shows both
3.0-kb and 4.7-kb bands. Amplification of the 3.0-kb band
without the 4.7-kb DNA (Figure 7A, lanes 1–4) indicates specific
amplification of cccDNA but not of the replicon plasmid. The
3.0-kb DNAs were cloned into the replicon plasmid backbone to
reconstruct the DHBV plasmids. Reconstructed 20 clones from
each sample were pooled and transfected into LMH cells to
measure viral replication activity. Importantly, this secondary
transfection was performed without A3G and UGI expression
vectors. At day 3 after transfection, cytoplasmic NC-DNA was
quantified by qPCR (Figure 7B). The reconstructed plasmid with
cccDNA from A3G-UGI transfectants showed a significant
decrease in NC-DNA production. Consistent with this data,
sequence analysis of the P gene in the reconstructed DHBV
plasmid revealed that extensive G-to-A hypermutation had
accumulated in the RCA products from A3G-UGI cotransfec-
tants (Figure 7C). The data shown in Figure 7B and C may
underscore the real impact of hypermutation, given that only
23.8% (720 bp) of the full viral genome per clone was sequenced
and that any destructive mutations on the DHBV promoter
region would have been rescued by the CMV promoter provided
by the backbone in the reconstructed plasmids (Figure S5).
Considering all the data, we concluded that nuclear UNG activity
repaired uracil bases in cccDNA that were generated by the
action of A3s.
Discussion
To avoid the mutagenic impact of dUTP misincorporation or
cytosine deamination, organisms have dUTPase and uracil DNA
glycosylases, including UNG. Some viruses such as poxviruses
(vaccinia viruses) or herpesviruses (HSV-1 and cytomegaloviruses)
also encode UNG homologs, and primate lentiviruses incorporate
host UNG into the virion through interaction with the viral Vpr
protein [29,32,59]. However, the involvement of uracil excision
activity during replication and infection of these viruses has not
been fully investigated. The effect of Vpr-bound UNG on the
deaminated HIV-1 DNA is apparently controversial, although it is
thought to be involved in DNA repair [31,32] or DNA
degradation [33] or to have no role [34,35,36]. Thus, it seems
that there is no unified view whether UNG plays a protective or
suppressive role in viral replication. In this study, using in vitro
models of HBV and DHBV, we investigated the role of UNG
activity in hypermutation and viral replication in the presence of
A3G. We found that UNG inhibition resulted in the enhancement
of A3G-induced NC-DNA hypermutation. This study for the first
time also found that the A3G protein induced cccDNA
hypermutation (Figures 5 and 7). The cccDNA hypermutation
was enhanced on UNG inhibition and subsequently resulted in
significant decrease in viral production (Figure 7), suggesting a
protective role of UNG for viral replication against cccDNA
hypermutation.
It has been difficult to determine which HBV intermediates
are catalyzed by UNG because HBV shuttles between the
cytoplasm and the nucleus during its life cycle. Plasmids can also
act as a target molecule. Stenglein et al. showed that
APOBEC3A induces C-to-U hypermutation in transfected
plasmids and that uracilated plasmids were processed by UNG
activity using UGI-expressing 293T cells [60]. In the present
study, APOBEC3A was not expressed in HepG2 and LMH cells
(Figure 2B). The contaminated DHBV plasmid does not
contribute to the results of cccDNA sequencing (Figures 7A
and S3C–E). Comparison of hypermutation frequencies of NC-
DNA, cccDNA, and pre-C mRNA from the same cell source
revealed that the mutation frequency of cccDNA was higher
than that of NC-DNA. G-to-A mutations were predominant in
cccDNA clones (Figure 5), whereas C-to-T mutation is a
characteristic feature of plasmid hypermutation [60]. The
transfected vector backbone did not accumulate hypermutation
(Figure S3E). Accordingly, we concluded that A3G does not
target the replicon plasmid and that the mechanism of cccDNA
hypermutation differs from that of plasmid hypermutation [60].
The observed G-to-A hypermutation is one of the prominent
features of cccDNA hypermutation. Predominant G-to-A
hypermutation in NC-DNA (Figures 5 and S3B), a precursor
of cccDNA, may partly account for the G-to-A cccDNA
hypermutation. However, it does not explain the higher
mutation frequency of exclusive G-to-A hypermutation in
cccDNA than that in NC-DNA. Further study is required to
clarify the mechanism of cccDNA hypermutation.
A3G is known to be encapsidated into NC and deaminate NC-
DNA. We propose that an additional deamination event by A3G
may occur during or after cccDNA formation in the nucleus.
Although the nuclear localization of GFP-A3G was not obvious in
DHBV-replicating LMH cells (Figure S4), the encapsidated A3G
may be able to enter the nucleus in the same manner as viral
rcDNA. Indeed, a recent HIV-1 study showed that infection with
Vif-deficient HIV-1 led to uracil accumulation in the host genome,
implying that Vif-sensitive A3s, including A3G, can also deami-
nate nuclear DNA [61]. We found that A3G and UGI
coexpression caused extensive nuclear cccDNA hypermutation
(Figures 5 and 7). Neither a UNG nor a Vpr homolog has been
identified in HBV, unlike the HIV-1 genome, and we failed to
detect UNG proteins in HBV NC (Figure S2). It is reasonable to
suggest that UNG excises uracils in the nucleus, resulting in
extensive nuclear cccDNA hypermutation in A3G-UGI transfec-
tants.
A proposed antiviral role for UNG is DNA degradation
following DNA cleavage of an abasic site generated by uracil
excision [13], although UNG is primarily considered a DNA
repair factor. In the present study, we compared viral production
between UGI presence and absence in A3G-expressing hepato-
cytes. Those experiments did not show obvious rescue of A3G-
mediated suppression of viral replication by UNG inhibition
(Figures 4 and 6). The A3G-mediated reduction of NC-DNA was
enhanced by UNG inhibition in prolonged culture (Figure 6B–E),
coincidentally with extensive hypermutation of cccDNA (Figure 5).
In this experimental setting, UNG-dependent DNA degradation
was not obvious. We accordingly propose that UNG removes
uracil residues on/after cccDNA formation in the nucleus and that
these uracil excisions contribute to reducing dysfunctional
mutagenesis induced by APOBEC deaminases (Figure S6).
Observation of hypermutated pre-C mRNA (Figure 5D) suggests
that hypermutated pgRNA is also transcribed from the cccDNA
and may contribute to the enhanced hypermutation in NC-DNA
by UNG inhibition (Figures 3 and S3B).
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Previous in vivo studies showed no evidence of cytidine
deamination in the DHBV genome during chronic infection
[62]; however, cccDNA sequences were not analyzed. In the
present study, several G-to-A/C-to-T mutations in DHBV
cccDNA were observed in LMH cells even without A3G
overexpression (Figure 5F), suggesting the contribution of endog-
enous deaminase activity. The chicken genome possesses only 3
AID/APOBEC members: AID, APOBEC2 (A2), and APOBEC4
(A4) [13,56,63]. In mammals, A2 is considered to play a role in
muscle development, and A4 may not have deaminase activity
[54,56]. There is a functional association of AID and UNG with
immunoglobulin gene diversification in human, mouse, and
chicken B cells [12,29,30,51]. Recent reports showed that human
AID endogenous expression was detected in hepatocytes after
TGF-b stimulation [64], and overexpression of AID caused HBV
hypermutation of NC-DNA [24]. In future studies, we plan to
assess the contribution of AID to antiviral activity against HBV
and DHBV.
APOBEC3G-mediated hypermutation of Vif-deficient HIV-1
caused deleterious effects on viral replication, whereas partial Vif
activity accelerated viral diversification [65,66]. Similarly, we
speculate that the balance between AID/APOBECs and UNG
activities on mutation frequency decides the consequence to
hepadnaviruses: deleterious mutations vs. diversification. DNA
sequencing showed the existence of several cccDNA clones having
a single G-to-A or C-to-T mutation (Figure 5D), a finding that
favors the concept of generation of clonal diversity by APOBEC
and UNG proteins. This study suggests a possible role of
APOBEC proteins as a mutator of HBV cccDNA. Because
mutation in cccDNA is direct resource of viral variants, we are
currently exploring the possibility that APOBECs and BER factors




The HBV replicon plasmids pHBV1.5 and pPB express all the
HBV viral gene products necessary for viral replication and are
under the control of the HBV and CMV promoters, respectively
[40,41,44]. The DHBV replicon plasmid pCSD3.5 was generated
by insertion of DHBV viral genomic DNA (equivalent to 1.17-
mer) into pCMV-script (Stratagene) (kindly provided by Dr. K.
Kuroki, Kanazawa University) [49]. The pCSD3.5DS plasmid was
generated by introduction of in-frame stop codons at positions
1327, 1346, and 1349 in the surface protein ORF without
Figure 7. UNG inhibition decreases the replication activity of DHBV cccDNA in the presence of A3G expression. (A) RCA products from
the cccDNAs. Expression vectors of A3G, UGI, and GFP were used for transfection of LMH cells together with the pCSD3.5DS replicon plasmid. After 7
days of cultivation, cccDNAs were purified from the nuclear fraction by Hirt extraction and treated with DpnI to digest transfected plasmids. The
cccDNAs were amplified with phi29 DNA polymerase. The DHBV replicon plasmid (pCSD3.5DS) was also reacted as a control. RCA concatemeric
products (indicated by an arrow) were digested with EcoRI and electrophoresed on agarose gel to verify successful amplification of the 3.0-kb full-
length DHBV genomic DNA (left side). The 4.7-kb fragment represents the pCSD3.5 backbone (see Figure S3A for the plasmid construct). (B) qPCR
analysis to assess replication activity of reconstructed replicon plasmids. The amplified full-length genomes from cccDNA were cloned into a pCSD3.5
backbone. Resulting reconstructed clones were used to transfect LMH cells without any other vectors (see Figure S5 for the experimental design).
DHBV NC-DNA was purified and quantified 3 days later. The graph shows the relative DHBV DNA level; the level of GFP transfectants was set as 1.
***P,0.005. (C) Mutation matrices for DHBV DNA of reconstructed replicon plasmids. A partial sequence of the P gene (720 bp) from 10
reconstructed replicon plasmid clones was analyzed for each sample. The number of clones containing C-to-T and G-to-A mutations is indicated
below. ****P,0.001. The statistical significance for the frequency of G-to-A mutations was calculated by chi-square test.
doi:10.1371/journal.ppat.1003361.g007
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affecting the P gene ORF [49]. Other expression vectors are listed
in Table S1.
Cell culture, treatment, retrovirus-mediated gene
transduction, and transfection
Cells (HepG2, Huh7, 293T, and LMH) and subsequent
transfectants were grown and maintained in Dulbecco’s modified
Eagle medium (DMEM; Sigma) containing 10% fetal bovine
serum, 100 U/mL penicillin, and 100 mg/mL streptomycin. IFNc
(recombinant IFNc-1a) was purchased from Shionogi. Tamoxifen
(Wako) was dissolved in ethanol (EtOH). A stable line of HBV-
expressing HepG2 cells was established using a standard method
[11]. In brief, HepG2 cells were transfected with linearized pPB,
and G418-drug selection with limiting dilution was performed. Of
the resulting transfectants, a cell line with a high level of HBV NC-
DNA was chosen among G418-resistant clones. Retrovirus-
mediated gene transduction was performed as described previously
[38,67]. In brief, retroviral vectors were transfected into packaging
platA cells (Cell Biolabs), and virus-containing culture superna-
tants were used for infection of HepG2 cells. Two days after
infection, 1 mg/mL puromycin (Wako) was added to eliminate
uninfected cells. Plasmid transfection was performed using Fugene
6 (Roche) according to the manufacturers’ instructions. The total
DNA amount (6 mg for 60-mm dish) for each transfection was kept
constant by adding GFP vector.
UNG assay
The UNG assay was performed as described previously, with
minor modification [39]. Cells were resuspended in HE buffer
[25 mM Hepes-KOH (pH 7.8), 1 mM EDTA, 1 mM DTT, 10%
glycerol] and fractured by freezing in liquid nitrogen and thawing.
A fluorescein isothiocyanate (FITC)-labeled 31-mer oligonucleo-
tide containing a central dU residue (59-AGCTTGGCTGCAGG-
TUGACGGATCCCCGGGA-39) was synthesized as a substrate.
An FITC-labeled 15-mer oligonucleotide (59-AGCTTGGCTG-
CAGGT-39) was also synthesized for use as a molecular size
marker. Approximately 10 pmol of substrate was incubated with
cell extracts for 2 h, and the resulting abasic sites were cleaved
with alkali and heat treatment. The reaction products were
separated by 6 M urea/20% polyacrylamide gel electrophoresis.
An FITC signal was visualized in an LAS imager system (FujiFilm)
and quantified by densitometry using ImageJ software.
Purification of HBV and DHBV DNA
Cytoplasmic HBV NC-DNA was purified as reported by
Gunther et al., with minor modifications [68]. In brief, the cells
were lysed with buffer [10 mM Tris-HCl (pH 8.0), 1 mM EDTA,
1% NP-40, 8% sucrose, proteinase inhibitor cocktail (Roche)].
After centrifugation, cytoplasmic supernatants were collected and
further treated with DNase I and RNase A. NCs were PEG-
precipitated and digested with proteinase K and sodium dodecyl
sulfate (SDS). Secreted DHBV particles were also precipitated
with PEG8000, followed by DNase I treatment and digestion with
proteinase K and SDS to extract viral DNA. For purification of
DHBV DNAs, LMH cells were lysed in 0.5% NP40 lysis buffer,
and the nuclei were collected by centrifugation to separate
cytoplasmic and nuclear fractions. The cccDNA extraction from
the nuclear fraction was performed using a modified Hirt
extraction procedure [69]. The nuclear pellet was lysed in
50 mM Tris–HCl (pH 7.5), 10 mM EDTA, and 2% SDS. After
20 min incubation at room temperature, 0.5 M KCl was added to
the lysate and incubated at 4uC overnight. From the supernatant
after centrifugation, DNA was purified by phenol:chloroform
extraction and ethanol precipitation. All purified DNA solutions
were treated with DpnI restriction enzyme to digest any
contaminating plasmid DNA.
Hypermutation analysis
The 3D-PCR procedure was performed as described previously,
with minor modifications [18,28]. Primers used for 3D-PCR are
shown in Table S2. For 3D-PCR of HBV, the first PCR was
performed as follows: 94uC for 5 min, 35 cycles of 94uC for 30 s,
50uC for 30 s, and 72uC for 30 s, and a final elongation step at
72uC for 3 min. The nested PCR was performed as follows: 94–
83uC for 5 min, 35 cycles of 94–83uC for 60 s, 45uC for 30 s, and
72uC for 30 s, and a final elongation step of 72uC for 3 min. For
DHBV NC-DNA, 1 round of 3D-PCR was performed using
primers indicated in Figure S3A [23]. Initial denaturation was for
5 min at 94–83uC, followed by 35 cycles of 30 s at 94–83uC, 30 s
at 55uC, and 2 min at 72uC, with a final elongation for 7 min at
72uC. For standard (94uC) PCR of cccDNA, a cccDNA-selective
primer set was used (Figure S3A and Table S2) [52,53]. Specific
amplification of cccDNA is shown in Figures S3C and S3D. To
determine the hypermutation frequency, PCR fragments from 3D-
PCR or standard PCR were cloned into T vectors (Promega), and
the indicated number of successful recombinant clones was
randomly selected and sequenced using ABI PRISM 3130
(Applied Biosystems).
Quantification of expression levels of transcripts and viral
DNAs
Total RNA was extracted using TRIsure (Bioline), treated by
amplification grade DNase I (Invitrogen), and reverse-transcribed
using an oligo-dT primer and the SuperScript III kit (Invitrogen).
For DHBV pre-C mRNA, a DHBV-specific primer was used in
the reverse transcription reaction. qPCR analysis was performed
using SYBR Premix Ex Taq (Takara) on an MX3000 thermo-
cycler (Stratagene) following the PCR protocol. Human AICDA,
A3B, A3C, A3DE, A3F, A3G, A3H, HPRT, DHBV pre-C, and
chicken HPRT expression levels were measured using PCR
conditions of 95uC for 1 min; 40 cycles of 95uC for 15 s, 55uC for
30 s, and 70uC for 30 s; and 1 cycle of 95uC for 1 min, 55uC for
30 s, and 95uC for 30 s. For A3A amplification, an annealing
temperature of 60uC was used.
For analysis of purified viral DNAs, qPCR was performed using
the following conditions: HBV, 40 cycles of 95uC for 15 s, 52uC
for 30 s, and 70uC for 30 s; DHBV, 40 cycles of 95uC for 5 s and
60uC for 20 s. HBV and DHBV DNA copy numbers were
determined using a pPB or pCSD3.5 plasmid standard curve,
respectively. Amplified fragments were designed to contain at least
2 DpnI sites to avoid amplification from contaminated plasmids.
Primer sequences are listed in Table S2.
Western blotting
Cells were lysed in SDS sample buffer, sonicated, boiled,
separated by 12% SDS-PAGE, and then transferred to a Hybond
ECL membrane (Amersham). The membrane was incubated in a
blocking buffer of 5% skim milk in phosphate-buffered saline
containing 0.1% Tween 20. Signals were detected using the
LAS1000 imager system. The antibodies used in this study were as
follows: rabbit anti-A3G (Sigma; raised against A3G peptide
[CQDLSGRLRAILQNQEN]), rabbit anti-GAPDH (G9545,
Sigma), mouse anti-FLAG (M2, Sigma), rabbit anti-ER (HC-20,
Santa Cruz Biotechnology), rabbit anti-UNG (ab23926, Abcam),
rabbit anti-HBc (B0586, Dako), anti-rabbit Igs-horseradish per-
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oxidase (HRP) (ALI3404, eBiosource), and rabbit and mouse IgG
Trueblot (eBioscience).
NAGE and Southern blotting for viral DNAs
NAGE analysis was performed as described previously
[21,22,48]. In brief, crude cytoplasmic extracts containing HBV
NC particles were loaded into a 1% agarose gel for electrophoresis
to separate intact capsid particles. After electrophoresis, the NC
particles were denatured with NaOH and transferred onto a nylon
membrane. HBV and DHBV DNAs were detected using a
double-stranded HBV and DHBV DNA probes spanning the
entire viral genome, respectively. Probe labeling and signal
development were performed using the AlkPhos direct labeling
system (Amersham), and the signals were detected using the
LAS1000 imager system.
RCA of DHBV cccDNA
Margeridon et al. previously demonstrated that the RCA
method specifically amplifies cccDNA with high fidelity but does
not amplify any other intermediate DNAs [57]. We followed their
method with minor modifications. In brief, DHBV cccDNA
purified by Hirt extraction (DpnI treated) was mixed with 8
DHBV-specific primers (Table S2); denatured at 95uC for 3 min;
cooled sequentially at 50uC for 15 s, 37uC for 15 s, and room
temperature; and reacted with the phi29 DNA polymerase and
buffers (New England Biolabs) at 37uC for 16 h. Note that the
DNA polymerase (phi-29 DNA pol) used in the RCA reaction can
polymerize DNA even with a uracil-containing DNA template
[70]. The RCA concatemerized product was converted to the
monomeric full-length DHBV genome by digestion with EcoRI,
where the DHBV sequence contains a single site, and was cloned
into the replicon vector backbone at the EcoRI site; thus, the full-
length DHBV genome in the original vector was replaced with the
corresponding fragment from the purified cccDNA. These
reconstructed plasmids were cloned, sequenced, and transfected
into LMH cells in order to analyze their replication activities (see
Figure S5 for experimental design).
RNAi analyses
Two UNG-specific siRNAs, two A3G-specific siRNAs and
control siRNA (Stealth Select grade) were purchased from
Invitrogen and were used to transfect using Lipofectamine 2000,
according to the manufacturer’s instructions. Cells and viruses
were analyzed 48 h after transfection.
Coimmunoprecipitation
Cells were lysed with IP lysis buffer [50 mM Tris-HCl (pH 7.1),
20 mM NaCl, 1% NP-40, 1 mM EDTA, 2% glycerol, a
proteinase inhibitor cocktail (Roche)]. After centrifugation, the
supernatants (cytoplasmic fraction) were incubated with anti-HBc
antibody (DAKO) and protein G sepharose (Amersham), and
passed through a micro BioSpin chromatography column
(BioRad). After the column was washed with the lysis buffer, the
coprecipitated proteins were used for Western blotting.
Statistical analysis
Statistical analyses were performed using GraphPad Prism
(GraphPad Software). ANOVA analysis was used for qPCR data.
The Kruskal–Wallis test with Dunn’s post test or Pearson’s chi-
square test were used for mutation analyses. P values less than 0.05
between experimental groups were considered statistically signif-
icant. For all graphs in this study, error bars indicate standard
error of the mean from triplicate samples.
Supporting Information
Figure S1 siRNA experiments of UNG and A3G. (A) Uracil
excision activity in the siRNA-transfected 293T cells. The 293T
cells were transfected with the indicated siRNAs, and after 48-h
incubation, uracil excision activities were determined. The signal
density for the 15-mer in the lane of 20 nM control siRNA was
defined as 100%. (B) Knockdown of UNG expression also
enhances hypermutation of HBV NC-DNA. The CMV-driven
HBV replicon plasmid (pPB), A3G vector, and the 20 nM siRNAs
were transfected into 293T cells. After 48 h, the cells were
harvested and the HBV NC-DNA was subjected to 3D-PCR
analysis. (C) Quantification of APOBEC3G expression in the
IFNc-stimulated cells. HepG2 cells were transfected with the
indicated A3G (or control) siRNAs and after 16 h, cells were
stimulated with 1000 U/mL IFNc for an additional 48 h. qRT-
PCR was performed to determine the expression level for A3G.
The expression level of control siRNA was defined as a 1-fold
change. (D) Alignment of hypermutated HBV sequences. PCR
fragments from the 87.2uC denaturation temperature reaction in
Figure 2D were excised from agarose gel and cloned into T
vectors, and subsequently four random selected clones were
sequenced from each sample. The reference sequence from the
pPB is shown above. Dots in the alignment represent identity with
the reference sequence.
(TIF)
Figure S2 Immunoprecipitation of NC and nuclear
localization of the UNG protein. (A). To detect any potential
physical binding between UNG and core proteins, immunopre-
cipitation was performed. pPB, FLAG-A3G (or FLAG-GFP), and
UNG2 expression vectors were transfected into 293T cells, as
indicated. At 48 h after transfection, the cells were harvested and
subjected to IP with anti-HBc antibody using cytoplasmic lysates.
The crude cytoplasmic extract was also blotted to verify UNG1,
UNG2 FLAG-A3G, FLAG-GFP, and core proteins. Nonspecific
binding of FLAG-A3G to protein G Sepharose beads was
observed (lane 6), but a much stronger signal was observed in
lane 8 than in lane 6. Signals for the core protein in the lanes 7 and
8 verified successful immunoprecipitation of the core protein to the
IP fraction. Although UNG2 was overexpressed, it was not
precipitated by the anti-HBc antibody. (B) Intracellular localiza-
tion of the UNG protein in HepG2 cells. pEGFP-UNG2 or
control pEGFP vector was transfected into HBV stably expressing
HepG2 cells. The nucleus was visualized with simultaneous
expression of the DsRed-NLS protein that mainly localized in
the nucleus. The EGFP protein was distributed in the nucleus and
cytoplasm, whereas UNG2 was localized only in the nucleus.
(TIF)
Figure S3 PCR amplification of DHBV DNAs. (A) Primer
positions to amplify DHBV NC-DNA, cccDNA, pre-C cDNA and
the replicon plasmid pCSD3.5 are shown. The viral genome in the
NC is a rcDNA form with gaps in both strands (left). (2) and (+)
represent minus- and plus-strand DNAs. Dotted line represents
region where plus-strand DNA may potentially not be synthesized.
In nucleus, the genome is converted into a cccDNA form (right).
Primers of pol-f and pol-r amplify both DNA forms. 3D-PCR of
NC-DNA in Figure 5C was performed with pol-f and pol-r
primers. ccc-f and ccc-r are cccDNA-selective primers that span
the gap region of rcDNA. DHBV genes are represented as gray
boxes. Primers to detect the cDNA of pre-C mRNA are same as
cccDNA-selective primers. Pre-C mRNA is not transcribed from
this plasmid but from cccDNA. Primers of neo-f and neo-r amplify
the partial sequence of the neomycin-resistant gene of the replicon
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plasmid. Numbers indicate nucleotide positions of the 3021-bp-
length DHBV genome starting at the unique EcoRI site. (B)
Mutation matrices of the NC-DNA for Figure 5D. The DHBV
NC-DNA fragments amplified with the standard PCR (94uC)
using pol-f and pol-r were cloned into a T vector. DNA sequences
from 10 clones were analyzed for each sample. Pie charts represent
the proportion of clones with G-to-A and C-to-T mutations for
left-side matrices. The total number of independent clones is
indicated in the center. The number of mutations is indicated on
the periphery of the pie segment. ***P,0.005. The statistical
significance for the frequency of G-to-A mutations was calculated
by chi-square test. (C) Selective PCR amplification for cccDNA.
The template DNA samples were serially diluted 1/5 and 1/25
and amplified by pol-f/pol-r or ccc-f/ccc-r primer set. P: pCSD3.5
DHBV replicon plasmid starting at 1010 copies per reaction. N:
nuclear Hirt-extracted DNA from pCSD3.5 transfectant. S: NC-
DNA from culture supernatant of pCSD3.5 transfectants. The
nuclear Hirt-extracted DNA containing cccDNA shows efficient
amplification in both PCR reactions, whereas plasmid and NC-
DNAs do not show efficient amplification in cccDNA-selective
PCR. (D) The cccDNA-selective PCR for the transfectants of
replication-defective replicon plasmid. pCSD3.5DS or the repli-
cation-defective DHBV replicon plasmid (pCSD3.5DP) was
transfected into LMH cells. After 3 days incubation, nuclear Hirt
extract was prepared by the same procedure as in Figure 5. DNA
samples were subjected to the cccDNA-selective PCR. (E)
Mutation matrix of the neomycin-resistant gene of the replicon
plasmid. pCSD3.5DP, A3G and UGI expression vectors were
transfected into LMH cells. The Hirt-extracted DNA from
transfectants at day 6 was subjected to neo-f/neo-r PCR. PCR
products were cloned into a T vector. DNA sequences from 12
clones were analyzed.
(TIF)
Figure S4 Intracellular localization of the A3G protein
in LMH cells. Surface-deficient DHBV and EGFP-A3G or
control EGFP vectors were used to transfect LMH cells. The
nucleus was visualized with simultaneous expression of the DsRed-
NLS protein. The EGFP protein was distributed in the nucleus
and cytoplasm, whereas majority of GFP signals from the EGFP–
A3G fusion protein come from cytoplasm.
(TIF)
Figure S5 Experimental scheme for Figure 7. The
cccDNAs were purified from the cells 7 days after transfection
and then treated with DpnI to digest any contaminating plasmids.
The cccDNA was amplified by RCA and digested using EcoRI to
produce 1 full-length copy of viral genomic DNA (Figure 7A).
These EcoRI fragments were cloned into the replicon plasmid
backbone (using the CMV promoter) to reconstruct the DHBV
replicon plasmids. After transformation of reconstructed plasmids,
20 transformed and reconstructed E. coli clones were selected
randomly from each sample. Twenty minipreps for each sample
were prepared and DNA concentrations were estimated. From the
20 reconstructed replicon plasmids, 0.5 mg were taken, pooled,
and used to transfect LMH cells without A3G or UGI vectors.
Three days after transfection, NC-DNA was purified and
quantified by qPCR (Figure 7B). For sequence analysis of
reconstructed clones, 10 clones were randomly selected from the
20 reconstructed clones and result is shown in Figure 7C.
(TIF)
Figure S6 A proposed model to explain how UNG
reduces uracil load on cccDNA. Intracellular viral lifecycle
together with possible role of UNG. pgRNA is transcribed from
cccDNA and the replicon plasmid when transfected. NC is
assembled in the cytoplasm from core and P proteins together with
pgRNA. In human hepatocytes, interferon induces APOBEC
proteins such as A3G. A3G is encapsidated in a subset of NCs and
induces hypermutation predominantly on the minus strand of
rcDNA, resulting in G-to-A hypermutation. In addition, A3G
inhibits minus strand DNA synthesis. After transportation into
nucleus, additional hypermutation may be induced by A3G, and
UNG repairs them during or after cccDNA formation. When
UNG activity is inhibited by UGI, the extensive hypermutation
remains in cccDNA, disrupting the genetic information for viral
replication. Pre-C mRNA is transcribed from cccDNA but not
from the replicon plasmid. When hypermutation does not affect
any processes required for transcription, hypermutated transcripts
such as pgRNA and pre-C mRNA are transcribed from
hypermutated cccDNA. The hypermutated pgRNA may be
encapsidated to enter a second viral lifecycle.
(TIF)
Table S1 List of plasmids used in this study.
(PDF)
Table S2 List of primers used in this study.
(PDF)
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